Acute Transcutaneous CO2 monitoring
Research type
Research Study
Full title
Study of the clinical effectiveness of transcutaneous CO2 monitoring in the acute setting as an alternative to arterial blood gas sampling.
IRAS ID
228887
Contact name
Susannah Bloch
Contact email
Duration of Study in the UK
0 years, 3 months, 0 days
Research summary
Arterial Blood Gas (ABG) sampling is a regularly used test which allows the clinician to assess the respiratory and metabolic state of the patient. It is used when patients are very unwell, for example with respiratory failure. One of the things that it allows clinicians to assess is the level of waste gasses in the blood, the pCO2. This reading is very important and often needs to be assessed multiple times. Unfortunately ABG tests are often very painful. Transcutaneous monitoring of pCO2 is already widely used in neonatal work and in sleep studies, however its clinical effectiveness in the acute setting has not been assessed. We aim to test if this non-invasive, low risk means of testing the pCO2 can be used as an alternative to the repeated and painful ABG, in the acute clinical setting and in patients who may have physiological disturbances.
REC name
London - South East Research Ethics Committee
REC reference
17/LO/1137
Date of REC Opinion
21 Aug 2017
REC opinion
Further Information Favourable Opinion